Clinical Consult

Using PARP Inhibitors in Frontline Maintenance Therapy of Ovarian Cancer
EP. 1: Overview of Ovarian Cancer
EP. 2: Genetic Testing for Ovarian Cancer
EP. 3: Role of Maintenance Therapy in Ovarian Cancer
EP. 4: Ovarian Cancer: FDA Approved PARP Inhibitors
EP. 5: SOLO-1 Trial
EP. 6: PRIMA Trial
EP. 7: PAOLA-1 Trial
EP. 8: Selecting Maintenance Therapy in Ovarian Cancer
EP. 9: Role of PARP Inhibition in Recurrent Ovarian Cancer
EP. 10: Future Directions for Treatment of Ovarian Cancer
Multiple Myeloma: Targeting BCMA in the Heavily Pretreated Population
EP. 1: Treatment Approaches for Heavily Pretreated RRMM
EP. 2: Heavily Pretreated RRMM: Patient Assessment & Treatment Selection
EP. 3: Selinexor for Heavily Pretreated RRRMM
EP. 4: Targeting BCMA in Relapsed/Refractory Multiple Myeloma
EP. 5: DREAMM-2 Safety and Efficacy Data in RRMM
EP. 6: Targeting BCMA in RRMM: Ongoing Trials With Novel Therapies
EP. 7: Targeting BCMA in RRMM With CAR T-Cell Therapy
EP. 8: BCMA-Targeted Therapy in Multiple Myeloma
Assessing the Impact of TAILORx on Breast Cancer Management
EP. 1: Assessing the Impact of TAILORx on Breast Cancer Management